Hasil Pencarian - Craig Granowitz

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis

    Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis oleh Peter P. Toth, Craig Granowitz, Michael Hull, Amy Anderson, Sephy Philip

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Prevalence of US Adults with Triglycerides ≥ 150 mg/dl: NHANES 2007–2014

    Prevalence of US Adults with Triglycerides ≥ 150 mg/dl: NHANES 2007–2014 oleh Wenjun Fan, Sephy Philip, Craig Granowitz, Peter P. Toth, Nathan D. Wong

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Estimated ASCVD risk according to statin use in US adults with borderline triglycerides: Results from National Health and Nutrition Examination Survey (NHANES) 2007–2014

    Estimated ASCVD risk according to statin use in US adults with borderline triglycerides: Results from National Health and Nutrition Examination Survey (NHANES) 2007–2014 oleh Wenjun Fan, Sephy Philip, Peter P. Toth, Craig Granowitz, Wong Nathan D.

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk

    High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With... oleh Peter P. Toth, Craig Granowitz, Michael Hull, Djibril Liassou, Amy Anderson, Sephy Philip

    Diterbitkan 2018-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study

    Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study oleh Christie M. Ballantyne, Mehar S. Manku, Harold E. Bays, Sephy Philip, Craig Granowitz, Ralph T. Doyle, Rebecca A. Juliano

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Global assessment improves risk stratification for major adverse cardiac events across a wide range of triglyceride levels: Insights from the KP REACH study

    Global assessment improves risk stratification for major adverse cardiac events across a wide range of triglyceride levels: Insights from the KP REACH study oleh Jeffrey R. Wagner, Jesse K. Fitzpatrick, Jingrong Yang, Sue Hee Sung, Amanda R. Allen, Sephy Philip, Craig Granowitz, David Abrahamson, Andrew P. Ambrosy, Alan S. Go

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Increased residual cardiovascular risk in U.S. veterans with moderately-elevated baseline triglycerides and well-controlled LDL-C levels on statins

    Increased residual cardiovascular risk in U.S. veterans with moderately-elevated baseline triglycerides and well-controlled LDL-C levels on statins oleh Sarah Leatherman, Sarah Leatherman, Ryan Ferguson, Ryan Ferguson, Cynthia Hau, Kelly Harrington, Kelly Harrington, Craig Granowitz, Sephy Philip, Peter Paul Toth, Deepak Bhatt, William Boden, William Boden

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI

    Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI oleh Benjamin E. Peterson, Deepak L. Bhatt, Ph. Gabriel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Rebecca A. Juliano, Lixia Jiao, Ralph T. Doyle, Craig Granowitz, C. Michael Gibson, Duane Pinto, Robert P. Giugliano, Matthew J. Budoff, Jean‐Claude Tardif, Subodh Verma, Christie M. Ballantyne

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Reduction of Revascularizations in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

    Reduction of Revascularizations in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC oleh Benjamin E. Peterson, M.D, Deepak L. Bhatt, M.D., M.P.H, Ph.Gabriel Steg, M.D, Michael Miller, M.D, Eliot A. Brinton, M.D, Terry A. Jacobson, M.D, Steven B. Ketchum, Rebecca A. Juliano, Ph.D., Lixia Jiao, Ph.D, Ralph T. Doyle, Jr., B.A, Craig Granowitz, M.D., Ph.D, C. Michael Gibson, M.S., M.D, Duane Pinto, M.D, Robert P. Giugliano, M.D., S.M, Matthew J. Budoff, M.D, Jean-Claude Tardif, M.D, Subodh Verma, M.D., Ph.D, Christie M. Ballantyne, M.D

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: